Skip to main content
TipRanks
Go Ultimate75% OFF

Sofinnova Partners Sas Insider Profile

4 Followers

Sofinnova Partners Sas, former Ten Percent Owner at Flexion Therapeutics, holds 4.22M shares in Cincor Pharma (Ticker: CINC), holds 2.10M shares in Flexion Therapeutics (Ticker: ~FLXN). Most recently, Sofinnova Partners Sas Bought ― shares of Cincor Pharma on Aug 17, 2022 for an estimated value of $4.00M.

Sofinnova Partners Sas's Trading History

CINC
Cincor Pharma
Aug 17, 2022―Informative Buy4.00M$122.66M
~FLXN
Flexion Therapeutics
Jan 19, 2015―Informative Sell200.00K$19.11M

You May Also Like

Sofinnova Partners Sas insider profile FAQ

What is the percentage of profitable transactions made by Sofinnova Partners Sas?
The percentage of profitable transactions made by Sofinnova Partners Sas is 100%.
What is the average return per transaction made by Sofinnova Partners Sas?
The average return per transaction made by Sofinnova Partners Sas is 55.10%.
What stocks does Sofinnova Partners Sas hold?
Sofinnova Partners Sas holds: ~FLXN, CINC stocks.
What was Sofinnova Partners Sas’s latest transaction?
Sofinnova Partners Sas’s latest transaction was an Informative Buy of $4.00M.
What was Sofinnova Partners Sas's most profitable transaction?
Sofinnova Partners Sas’s most profitable transaction was an Informative Buy of CINC stock on January 13, 2022. The return on the trade was 80.90%.
What is Sofinnova Partners Sas's role in Flexion Therapeutics?
Sofinnova Partners Sas's role in Flexion Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.